Laserfiche WebLink
AMENI ENT #19 <br />requir€ testing and sh.ipping to Laboratory R.esponse t{et\Al{}rk (LRN} C|r CDc laborator,esdesignated for testing. <br />Rapidly report te.st results between the laboratory, the public health department,heattlrcare f,acilities, and cDc to support public health investigatiorrs-Test a sarnp|e of outpatients vr.ith ll-l or A,Rl for COVID-3-9 and other respir-atory viruses andcomplete the following: <br />- Report r,rreekly percent positive COVID-1g outpauent visits by age group- <br />- Determine the rate of lLf,/ARl outpatient visits and th€ rate of covtD-l-o-confirrnedlLl pauents- <br />- This allowable activity is similar to "sentinel COVTD-19 Surveillance, March <br />2o2or and ll-lDJet Enlrancernents in 2of-9." lt rnay include. but is not lirnitedto the *;5#:S <br />testins at pubric heatth laboratories- Describe rnodification of protocols and validation of speclmen typeother than.N.P/OP s\Arabt including valadation of different sr,vab <br />types arld self-swabbing for C()!v/TD-19 <br />Collaborate r,vnh Emerging lnf,ection Program an.d lnfluenza Flospita]ization SurveillenceI{et\A'(}rkto modiif existing FluSurv-t\IET program for COVTD-19. <br />Enhance laboratory surge capacity plans. <br />Detei:mine frlaxirnum lab testang c€pacity and establish prioritizat-on criteria andcoriting,ency plans for testing af rnaxirnl!m capacity is reached., <br />VVcrrk vuitFr laborat,ory partners to ensure lebs receive updated guidance on appropriatetesting algorithrns and semple types as additional irif,{3rrnation is acquired, <br />EnsLlre cl.ear gljadarrce is cornrnunicat€d to clinical labs and physicians on horr to obtainappropriate l.ab t'esting. <br />g <br />o <br />c <br />g <br />o <br />€ <br />€ <br />Appropriately collect and I and other clinica ratory specimens th,at <br />Provid€firr irn individuals- <br />Ensure data rna,nagernent systerns are in place and meet the needs of the jur:llsdidiil,cln. <br />lrnplement analYsis,'visualization, an{ reporting for surwelltance and other available data tosuPport underltdnding of the otrtbreak, transmission, and impact of interventions- <br />Exa rnpl€s of allovuabl.e acfivities: <br />o <br />o <br />Ensure efficiea data collection- <br />Data Management <br />Ensure abilityto rapidlyexchange tlata r,rrith prlbl-c health paFtners <br />e piderniologica! a nd la bo rato ry s ur\/ei llarrce - <br />6 <br />crr<fam€ {^r <br />(inch:ding CE}€l and <br />a Coordinete deta <br />other relevant partn.erE- <br />Dornafor <br />Exhibit A, Statements of Work <br />Revised as ofJanuary 15,2021 <br />Page.25 of 30 Contract Number CLHL8249 - 19